The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Effectiveness of Long-Acting Reversible Contraception
Open accessAbstract
BACKGROUND: The rate of unintended pregnancy in the United States is much higher than in other developed nations. Approximately half of unintended pregnancies are due to contraceptive failure, largely owing to inconsistent or incorrect use. METHODS: We designed a large prospective cohort study to promote the use of long-acting reversible contraceptive methods as a means of reducing unintended pregnancies in our region. Participants were provided with reversible contraception of their choice at no cost. We compared the rate of failure of long-acting reversible contraception (intrauterine devices [IUDs] and implants) with other commonly prescribed contraceptive methods (oral contraceptive pills, transdermal patch, contraceptive vaginal ring, and depot medroxyprogesterone acetate [DMPA] injection) in the overall cohort and in groups stratified according to age (less than 21 years of age vs. 21 years or older). RESULTS: Among the 7486 participants included in this analysis, we identified 334 unintended pregnancies. The contraceptive failure rate among participants using pills, patch, or ring was 4.55 per 100 participant-years, as compared with 0.27 among participants using long-acting reversible contraception (hazard ratio after adjustment for age, educational level, and history with respect to unintended pregnancy, 21.8; 95% confidence interval, 13.7 to 34.9). Among participants who used pills, patch, or ring, those who were less than 21 years of age had a risk of unintended pregnancy that was almost twice as high as the risk among older participants. Rates of unintended pregnancy were similarly low among participants using DMPA injection and those using an IUD or implant, regardless of age. CONCLUSIONS: The effectiveness of long-acting reversible contraception is superior to that of contraceptive pills, patch, or ring and is not altered in adolescents and young women. (Funded by the Susan Thompson Buffet Foundation.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Disparities in Rates of Unintended Pregnancy In the United States, 1994 and 2001
Finer, L. B., & Henshaw, S. K. (2006) · Perspectives on Sexual and Reproductive Health · doi:10.1363/3809006 · Cited by 1,557
Unintended pregnancy in the United States: incidence and disparities, 2006
Finer, L. B., & Zolna, M. R. (2011) · Contraception · doi:10.1016/j.contraception.2011.07.013 · Cited by 1,291
The Best Intentions: Unintended Pregnancy and the Well-Being of Children and Families
Guttmacher, S., Brown, S. S., & Eisenberg, L. (1998) · Journal of Public Health Policy · doi:10.2307/3343096 · Cited by 710
Use of Contraception in the United States, 1982: (605102007-001)
Bachrach, C. A., & Mosher, W. D. (1984) · PsycEXTRA Dataset · doi:10.1037/e605102007-001 · Cited by 689
The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception
Secura, G. M., Allsworth, J. E., Madden, T., Mullersman, J. L., & Peipert, J. F. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.04.017 · Cited by 665
Self-citationIntrauterine devices and pelvic inflammatory disease: an international perspective
Farley, T. M. M., Rowe, P. J., Meirik, O., Rosenberg, M. J., & Chen, J.-H. (1992) · The Lancet · doi:10.1016/0140-6736(92)91904-m · Cited by 609
Continuation and Satisfaction of Reversible Contraception
Peipert, J. F., Zhao, Q., Allsworth, J. E., Petrosky, E., Madden, T., Eisenberg, D., & Secura, G. (2011) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31821188ad · Cited by 564
Self-citationEstimates of contraceptive failure from the 2002 National Survey of Family Growth
Kost, K., Singh, S., Vaughan, B., Trussell, J., & Bankole, A. (2008) · Contraception · doi:10.1016/j.contraception.2007.09.013 · Cited by 444
Contraceptive Failure Rates: New Estimates from the 1995 National Survey of Family Growth
Fu, H., Darroch, J. E., Haas, T., & Ranjit, N. (1999) · Family Planning Perspectives · doi:10.2307/2991640 · Cited by 294
The effects of Implanon® on menstrual bleeding patterns
Mansour, D., Korver, T., Marintcheva-Petrova, M., & Fraser, I. S. (2008) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625180801959931 · Cited by 238
Cited by
Our future: a Lancet commission on adolescent health and wellbeing
Patton, G. C., Sawyer, S. M., Santelli, J. S., Ross, D. A., Afifi, R., Allen, N. B., Arora, M., Azzopardi, P., Baldwin, W., Bonell, C., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00579-1 · Cited by 3,785
Declines in Unintended Pregnancy in the United States, 2008–2011
Finer, L. B., & Zolna, M. R. (2016) · New England Journal of Medicine · doi:10.1056/nejmsa1506575 · Cited by 1,989
Sammaritano, L. R., Bermas, B. L., Chakravarty, E. E., Chambers, C., Clowse, M. E. B., Lockshin, M. D., Marder, W., Guyatt, G., Branch, D. W., Buyon, J., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41191 · Cited by 790
Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems
Baryakova, T. H., Pogostin, B. H., Langer, R., & McHugh, K. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00670-0 · Cited by 492
Preventing Unintended Pregnancies by Providing No-Cost Contraception
Peipert, J. F., Madden, T., Allsworth, J. E., & Secura, G. M. (2012) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e318273eb56 · Cited by 469
Self-citationProvision of No-Cost, Long-Acting Contraception and Teenage Pregnancy
Secura, G. M., Madden, T., McNicholas, C., Mullersman, J., Buckel, C. M., Zhao, Q., & Peipert, J. F. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1400506 · Cited by 400
Self-citationContraception Selection, Effectiveness, and Adverse Effects: A Review
Teal, S., & Edelman, A. (2021) · JAMA · doi:10.1001/jama.2021.21392 · Cited by 336
Sammaritano, L. R., Bermas, B. L., Chakravarty, E. E., Chambers, C., Clowse, M. E. B., Lockshin, M. D., Marder, W., Guyatt, G., Branch, D. W., Buyon, J., et al. (2020) · Arthritis Care & Research · doi:10.1002/acr.24130 · Cited by 323
Adolescent and Young Adult Oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Coccia, P. F., Pappo, A. S., Beaupin, L., Borges, V. F., Borinstein, S. C., Chugh, R., Dinner, S., Folbrecht, J., Frazier, A. L., Goldsby, R., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0001 · Cited by 295
History of oral contraceptive drugs and their use worldwide
Christin-Maitre, S. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.11.004 · Cited by 272
Worldwide use of intrauterine contraception: a review
Buhling, K. J., Zite, N. B., Lotke, P., & Black, K. (2014) · Contraception · doi:10.1016/j.contraception.2013.11.011 · Cited by 267
(2015) · PubMed · Cited by 132
Committee Opinion No. 602: Depot Medroxyprogesterone Acetate and Bone Effects
(2014) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000450758.95422.c8 · Cited by 107
Use of Depot Medroxyprogesterone Acetate Contraception and Incidence of Bone Fracture
Lanza, L. L., McQuay, L. J., Rothman, K. J., Bone, H. G., Kaunitz, A. M., Harel, Z., Ataher, Q., Ross, D., Arena, P. L., & Wolter, K. D. (2013) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e318283d1a1 · Cited by 78
Hyperinsulinaemic androgen excess in adolescent girls
Ibáñez, L., Ong, K. K., López-Bermejo, A., Dunger, D. B., & de Zegher, F. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.58 · Cited by 56
Compliance with pregnancy prevention measures during isotretinoin therapy
Collins, M.-K., Moreau, J. F., Opel, D., Swan, J., Prevost, N., Hastings, M., Bimla Schwarz, E., & Korb Ferris, L. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.08.034 · Cited by 44
Modesto, W., Bahamondes, M. V., & Bahamondes, L. (2015) · Journal of Women's Health · doi:10.1089/jwh.2014.5077 · Cited by 36
“1,2 However, there are controversies concerning long-time exposure and its effects on bone mineral density (BMD), not only during its use but also following discontinuation, after menopause, and with respect to fracture risk.”
Updated guidance for safe and effective use of contraception
Tepper, N. K., Curtis, K. M., Jatlaoui, T. C., & Whiteman, M. K. (2016) · Journal of Women's Health · doi:10.1089/jwh.2016.6191 · Cited by 14
Contraceptive considerations for women with gastrointestinal disorders
Sridhar, A., Cwiak, C. A., Kaunitz, A. M., & Allen, R. H. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4383-z · Cited by 6
Metadata
- Authors
- Winner, B., Peipert, J. F., Zhao, Q., Buckel, C., Madden, T., Allsworth, J. E., & Secura, G. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-05-24
- Volume
- 366
- Issue
- 21
- Pages
- 1998-2007
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2140871293
- Cited by
- 1,154
- References
- 17
- FWCI
- 101.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.